NICE International Advisory Group: members
Professor Anthony Culyer, University of York, UK; University of Toronto, Canada (Chair)
Tony Culyer lives and works on each side of the Atlantic. He is a professor of Economics at the University of York (UK) and is the Ontario Research Chair in Health Policy and System Design at the University of Toronto (Canada). He chairs the R&D Committee of the National Institute for Health & Clinical Excellence, the Policy and Editorial Committees of the Office of Health Economics (both UK and the Research Advisory Council of the Workplace Safety & Insurance Board (Ontario, Canada). He is on various other advisory bodies in the UK and Canada. He is a founding editor of the Journal of Health Economics, a Founding Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal College of Physicians of London, a Commander of the British Empire and has an honorary doctorate from the Stockholm School of Economics. At York he was Head of the Department of Economics & Related Studies 1986-2001. He was Pro-Vice-Chancellor and subsequently Deputy Vice-Chancellor at York 1991-7. 2003-6 he was Chief Scientist at the Institute for Work & Health in Toronto.
Dr Rob Hecht, Results for Development, USA
Rob Hecht, Managing Director, joined Results for Development in April 2008, and is currently managing a growing portfolio of projects analyzing policy barriers and solutions related to AIDS and health financing and improving R&D and access to new health technologies in developing countries. Before coming to Results for Development, Dr. Hecht spent four years as vice president for Policy and Advocacy at the International AIDS Vaccine Initiative. Prior to this, he had a 20 year tenure at the World Bank, where he occupied a number of senior posts including manager of the Bank's central unit for Health, Nutrition, and Population, with oversight for global strategies, knowledge, technical services, and partnerships; chief of operations for the Human Development Network; principal economist in the Latin America region, and member of the core team and a lead author of the 1993 World Development Report, "Investing in Health." From 1987 to 1996, Dr. Hecht was responsible for World Bank sponsored studies and projects in health in Africa and Latin America, most notably in Zimbabwe and Argentina. Dr. Hecht served as a director of the Joint United Nations Program on HIV/AIDS (UNAIDS) from 1998 to 2001, where he managed technical units based in South Africa, Cote d'Ivoire, and Thailand, as well as in Geneva. He received his undergraduate degree from Yale and his doctorate from Cambridge University.
Professor Shah Ebrahim, London School of Hygiene & Tropical Medicine, UK; South Asia Centre for Chronic Disease, New Delhi, India
Shah Ebrahim is an epidemiologist with a clinical background in Geriatric Medicine. His research spans genetic epidemiology, the causes of heart disease and stroke in women, the effects of migration on obesity and diabetes in India, and disability in old age. He set up the British Women's Heart & Health Study - national cohort study of British women - in 1999. He also set up the Cochrane Heart Group which produces systematic reviews of the effects of interventions for heart diseases.
He is co-editor of the International Journal of Epidemiology. He chaired the Wellcome Trust Populations and Public Health funding committee since its inception to April 2007 and is a member of the Wellcome Trust Populations and Public Health Strategy Panel. He was a non-executive member of National Institute for Clinical and Public Health Excellence (NICE) from 2005-2008.
He is currently setting up a centre for research on chronic diseases in New Delhi funded by Wellcome Trust and is working closely with colleagues at LSHTM and 12 other British Universities on a programme of building research and educational capacity to strengthen public health in India - also funded by the Wellcome Trust. He has published over 350 peer reviewed scientific papers and has written/edited 10 textbooks in the field of epidemiology, health services research and genetic epidemiology.
Dr Carlos Santos Burgoa, Pan-American Health Organization
Carlos Santos Burgoa is a graduate of the Medical School of the National Autonomous University of México. He obtained his Masters in Public Health and Ph.D, in Environmental and Occupational Epidemiology from the Johns Hopkins School of Hygiene and Public Health. He was Chair of Epidemiology and Biostatistics and later on for six years Dean of The School of Public Health of Mexico. He was founder and General Director of the Work, Environment and Health Institute, a private academic and consulting organization based in Mexico City. He was the General Director of Environmental Health and General Director for Equity and Health Director at the Secretariat of Health in Mexico, where he led the effort of the health development initiatives at the Secretariat, in charge of the implanting innovations required by the new health reforms in Mexico, rapidly bringing knowledge and research into policy and health development. He has published extensively and has consulted for the Rockefeller Foundation in Africa, the Mexican Health Foundation, the Mexican Oil Corporation, the Mexican Ministry of Health, the Mexico City Government, the Occupational, Health and Safety Administration and the Environmental Protection Agency of the USA, the World Bank, the World Health Organization, the Commission for Environmental Cooperation, the United Nations Environment Program and the United Nations Development Program. He is an elected fellow of the National Academy of Medicine in Mexico.
Dr Tsung-Mei Cheng, Princeton University, USA
Tsung-Mei Cheng is an expert on comparative health systems with an emphasis on Asian countries. She is also Co-Founder of the Princeton Conference, an annual national conference on health policy that brings together the U.S. Congress, government, and the research community on issues affecting health care in the United States. Cheng was an adviser in 2003 to the Strategic Review Board of the Science and Technology Advisory Group (STAG), a body charged with advising the Office of the Premier of Taiwan, the Republic of China, on the development of science and technology. Cheng is a member of the Advisory Board of America-China Medical Association, as well as the International Advisory Group of AcademyHealth, the professional association of health services researchers. Cheng writes and lectures internationally on topics ranging from single payer systems, health care quality, financing, pay for performance focusing on East Asian health systems, to the impact of the WTO and GATS on national health policy. Currently she is working on cross-national comparisons of health systems in East Asia focusing on health reforms in China and Taiwan. Cheng is the host, writer and executive editor of the International Forum, a Princeton University television program on international affairs focusing on economic, political, social, global-health, and security issues.
Professor Rodrigo R Soares, Pontifícia Universidade Católica do Rio de Janeiro, Brazil
Rodrigo R. Soares is Associate Professor of Economics at the Catholic University of Rio de Janeiro (PUC-Rio). He received his Ph.D. in Economics from the University of Chicago in 2002. His dissertation, entitled “Life Expectancy, Educational Attainment, and Fertility Choice: The Economic Impacts of Mortality Reductions,” earned the 2003 Brazilian National Award for best Ph.D. Dissertation in Economics (Prêmio Haralambos Simeonidis). Rodrigo's research centers on development economics, ranging from health and population, to corruption, institutions, and crime. His work has appeared in various scientific journals, including American Economic Review, Journal of Political Economy, Journal of Public Economics, and Journal of Development Economics, among others. In 2006, he was awarded - together with co-authors Gary S. Becker and Tomas J. Philipson - the Kenneth J. Arrow Award from the International Health Economics Association for the best paper published in the field of Health Economics during 2005. Rodrigo is also affiliated with the University of Maryland (on leave since 2007), and is a fellow of the Brazilian Academy of Sciences, the NBER, the IZA, and the Maryland Population Research Center. He is also Associate Editor of Economía, the Journal of the Latin American and Caribbean Economic Association.
Professor Martin McKee, European Public Health Observatory and London School of Hygiene and Tropical Medicine, UK
Martin McKee qualified in medicine in Belfast, Northern Ireland, with subsequent training in internal medicine and public health. As Professor of European Public Health at the London School of Hygiene and Tropical Medicine he co-directs the European Centre on Health of Societies in Transition (ECOHOST), a WHO Collaborating Centre that comprises the largest team of researchers working on health and health policy in central and Eastern Europe and the former Soviet Union. He is also research director of the European Observatory on Health Systems and Policies, a unique partnership of universities, national and regional governments, and international agencies. He has published over 400 scientific papers and 23 books and is an editor of the European Journal of Public Health and a member of numerous editorial boards, as well as being an editorial consultant to The Lancet. He sits on a number of advisory boards in Europe and North America, in both the public and private sectors, is a Fellow of the Royal Colleges of Physicians of the UK and Ireland and the UK Faculty of Public Health.
Mrs Martha Gyansa-Lutterodt, Ministry of Health, Ghana
Martha Gyansa-Lutterodt is a Pharmacist with over 20 years experience in health systems strengthening and a health policy analyst. She is the Head of Ghana National Drugs Programme of the Ministry of Health in which role she oversees the formulation of national strategies to ensure broad and inclusive access to medicines for all people living in Ghana. She obtained her B Pharm degree at the University of Science and Technology Kumasi Ghana, a post-graduate Certificate in Health Management and also an MA in Health Management Planning and Policy at the University of Leeds, UK. Mrs. Gyansa-Lutterodt managed the introduction of a comprehensive national drug policy in Ghana and coordinated the production and dissemination of Ghana's Standard Treatment Guidelines and Essential Medicines List and currently with the sixth edition of the latter under review. She also managed, coordinated and has been involved in most pharmaceutical sector surveys in Ghana. She has vast experience in promoting rational use of medicines in Ghana and has consulted on drug access and quality issues for a wide range of organizations and initiatives, local and international, such as the Global Health Council's Drug Resistance Working Group. As one of the drafters of Ghana's Health Policy, she believes in evidence-based policy decision making and also moving health policies into practice that provides sustainable outcomes especially for the most vulnerable.
Kees de Joncheere, World Health Organziation
Kees de Joncheere was appointed Director Essential Medicines and Pharmaceutical Policies in WHO Headquarters in Geneva, as of May 2012. From October 2011 he had served as WHO Representative and Head of Country Office in Kyiv, Ukraine. Before that he was the WHO Regional Adviser for the area of Health Technologies and Pharmaceuticals in the WHO Regional Office for Europe, based in Copenhagen. He coordinated the WHO country assistance in the pharmaceutical sector for Central and Eastern Europe, as well as the Newly Independent States; and collaborated closely with Western European countries and the European Commission on pharmaceutical policy issues, among others through the Pharmaceutical Pricing and Reimbursement Information project. He also co-authored WHO reviews of the Technology Appraisal programme (2003) and the Clinical Guidelines programme (2006) of the National Institute for Health and Clinical Excellence (NICE) in England, and of the Health Information programme (2010) of the German Institute for Quality and Efficiency in Health Care (IQWiG). He has been working on the issues of access to HIV/AIDS medicines in Eastern Europe and on the agenda of “Public Health, Innovation and Intellectual Property”.
He holds Master`s degrees in pharmacy and business administration from the Universities of Groningen and Amsterdam in the Netherlands, and from National University, San Diego, USA / San Jose, Cost Rica. From 1985 to 1996 he worked with PAHO/WHO in Latin America (Central America, Brazil and the Mercosur countries) and before that on secondment of the Dutch government in then North Jemen. In the pharmaceutical years his particular interest were in public policy on medicines, especially on pharmaceutical pricing and reimbursement, as well approaches to strengthen medicines regulation and improve the use of medicines. He was co-editor of the WHO publication Drugs and Money, 7th edition, 2002, and author of several articles and book chapters on pharmaceutical issues.
Emeritus Professor Lloyd Sansom AO, Dept Health and Ageing, Commonwealth of Australia
Professor Sansom graduated in pharmacy in 1962 and completed his PhD in Biophysical Chemistry at the University of Adelaide in 1972.He retired in 2000 as the Head of the School of Pharmacy and Medical Sciences at the University of South Australia. He was appointed the Chair of the Pharmaceutical Benefits Advisory Committee in January 2001 having been the Chair of the Australian Pharmaceutical Advisory Council since 1991. Professor Sansom has been involved in the development of Australia's National Medicines Policy. He holds the title of Emeritus Professor at the University of South Australia. In 2002 Professor Sansom was made an Officer in the Order of Australia for contributions to the development of national pharmaceutical policy.
Amanda Glassman, Center for Global Development, USA
Amanda Glassman is the Director of Global Health Policy and a research fellow at the Center for Global Development. She has 20 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world. Prior to her current position, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led health economics and financing knowledge products and policy dialogue with member countries. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics and is editor and co-author of the books From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010) and The Health of Women in Latin America and the Caribbean (World Bank 2001).
Krisantha Weerasuriya, World Health Organization (WHO) (Observer)
Dr Krisantha Weerasuriya is a Sri Lankan Clinical Pharmacologist. His basic and postgraduate medical education was in Sri Lanka, and he trained in the United Kingdom as Clinical Pharmacologist. He is a Fellow of the Royal College of Physicians of London and has a PhD in Clinical Pharmacology from the University of London. He was the Professor of Pharmacology, Faculty of Medicine, University of Colombo, Sri Lanka and the Secretary of the Drug Registration Committee on the Ministry of Health, Sri Lanka. He was also a Clinical Trial Monitor for new drugs in malaria and leishmaniasis for the Tropical Disease Research section in WHO in Asia and Africa, and a Regional Adviser, Essential Drugs and Medicines Policy in the South East Asia Regional Office of the World Health Organisation.
His current position is Medical Officer, Medicines Access and Rational Use (MAR), Essential Medicines and Pharmaceutical Policies (EMP) in World Health Organization, in Geneva, Switzerland.
This page was last updated: 10 April 2013